Company: RGNT
Filing Date: 2025-09-30
Form Type: F-1/A
Source: 0001213900-25-093302
Chunk: 289

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-09-30
Form: F-1/A
Chunk 289
---
 accumulated deficit was $45,374. The Company
has funded its operations to date primarily through equity financing, loans and the issuance of convertible notes. Management expects
that the Company will continue to generate losses from the development, clinical trials, regulatory activities of its product and from
the general administration of its business, which will result in negative cash flow from operating activity.

<div align='center'>F-35</div>

REGENTIS BIOMATERIALS LTD.

NOTES TO THE UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS

U.S. dollars in thousands, except share and per share data

| NOTE 1: | GENERAL (Cont.) |

While the Company has been successful
in raising financing in the past, it is not probable that the Company will be able to successfully obtain additional financing on a timely
basis on terms acceptable to the Company, or will provide the Company with sufficient funds to meet its objective.

Such conditions raise substantial
doubts about the Company’s ability to continue as a going concern. Management’s plans include, but are not limited to an
initial public offering (the “IPO”) in the United States.

In addition, in the event the Company
is unable to have its convertible notes converted as planned or their repayment date deferred, the Company will not have sufficient cash
flows and liquidity to finance its business operations as currently contemplated. If such sufficient financing or payment deferral is
not received timely, the Company would then need to pursue a plan to license or sell its assets, seek to be acquired by another entity,
cease operations and/or seek bankruptcy protection. The Company’s financial statements do not reflect any adjustments that might result
from the outcome of this uncertainty.

| e. | Impact of the “Iron Swords” War on Israel |

In October 2023, Hamas terrorists
infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Following
the attack, Israel’s security cabinet declared war against Hamas and commenced a military campaign against Hamas and other terrorist
organizations in parallel to their continued rocket and terror attacks. In addition, Hezbollah have attacked military and civilian targets
in Northern Israel, to which Israel has responded, including through increased air and ground operations in Lebanon. Since the war broke
out, our operations have not been adversely affected by this situation, and we have not experienced disruptions to our development. On
June 13, 2025, in light of continued nuclear threats and intelligence assessments indicating